DR. PETER ANTHONY RIENZI M.D. NPI 1336177823

NPI Details

DR. Peter Anthony Rienzi, M.D. is an internal medicine in Schenectady, NY with 43 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Peter Anthony Rienzi, M.D. NPI is 1336177823. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

2546 BALLTOWN RD
SUITE 200
SCHENECTADY, NY
ZIP 12309-079
Phone: (518) 374-1444
Fax: (518) 374-0491

The NPI 1336177823 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Automated urinalysis test (HCPCS:81003)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Hemoglobin a1c level (HCPCS:83036)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Vitamin d-3 level (HCPCS:82306)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urine microalbumin (protein) level (HCPCS:82043)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Blood test, clotting time (HCPCS:85610)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Bacterial colony count, urine (HCPCS:87086)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Ferritin (blood protein) level (HCPCS:82728)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Folic acid level, serum (HCPCS:82746)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Influenza vaccine, quadrivalent derived from recombinant dna (HCPCS:90682)

The enumeration date for this NPI number is 6/30/2006 and was last updated on 1/31/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.